Search results for:
Burnaby Hospital deploys Steriwave
Burnaby Hospital in British Columbia has deployed Steriwave nasal photodisinfection to help prevent surgical site infections and optimize patient outcomes. Vancouver, British Columbia, Canada - September 29, 2023 Burnaby Hospital, a large community hospital in British Columbia, has initiated use of Ondine Biomedical’s (OBI:LON) [...]
Montreal Heart Institute pilots Steriwave
Second Quebec-based hospital pilots nasal photodisinfection to reduce antibiotic resistance Vancouver, British Columbia, Canada - September 21, 2023 The world-renowned Montreal Heart Institute and Hôpital Fleurimont, University of Sherbrooke (CHUS) in Sherbrooke, Quebec are piloting nasal photodisinfection to prevent post-operative infections in an era [...]
Steriwave proven highly effective against XDR bacteria
Ondine Biomedical presents research demonstrating high efficacy against Extensively Drug-Resistant (XDR) bacteria at ICPIC 2023, Geneva Vancouver, British Columbia, Canada - September 14, 2023 Canadian life sciences company Ondine Biomedical Inc. (LON: OBI) has presented new research at the 2023 International Consortium on Prevention & [...]
Steriwave evaluation at major heart institute
The evaluation at the Mazankowski Alberta Heart Institute in Edmonton, Canada, a world-leading centre for complex cardiac care and surgery, will see around 800 cardiac surgery patients treated with Steriwave in order to prevent surgical site infections (SSIs) Vancouver, British Columbia, Canada - September 12, 2023 [...]
Ondine to present new AMR research at ICPIC, Geneva
Ondine Biomedical to present new research on efficacy of photodisinfection against key gram-negative bacteria driving antimicrobial resistance threat Vancouver, British Columbia, Canada - August 29, 2023 Canadian life sciences company Ondine Biomedical Inc. will present new research on the efficacy of antimicrobial photodynamic therapy, known [...]
BBC News features first NHS pilot of Steriwave
BBC Look North evening news feature: A pioneering laser treatment which could cut the risk of drug-resistant infections after operations is being trialled for the first time in the UK. A six-month NHS pilot will see 500 patients given Ondine Biomedical's Steriwave® nasal photodisinfection at Pontefract Hospital in [...]
Ondine commences first NHS Steriwave® pilot
First NHS pilot of nasal photodisinfection for the prevention of post-surgical infections starts at Mid Yorkshire Teaching NHS Trust Vancouver, British Columbia, Canada - August 1, 2023 The pilot will assess the effect of nasal photodisinfection on 500 elective surgery patients at Pontefract Hospital Mid [...]
Ondine receives Impact Award at IPA World Congress
Ondine Biomedical is recipient of the TAYYABA HASAN IMPACT AWARD at 18th IPA World Congress, Finland Vancouver, British Columbia, Canada - July 17, 2023 Ondine Biomedical (LON:OBI) was awarded the TAYYABA HASAN IMPACT AWARD at the 18th World Congress of International Photodynamic Association (IPA) [...]
Photodisinfection cuts COVID in meat processing plant
Newly published results show treatment with Ondine’s nasal photodisinfection dramatically reduced COVID-19 rates at Canadian meat processing plant Vancouver, British Columbia, Canada - June 22, 2023 (updated with corrections August 16, 2023) Weekly nasal photodisinfection of 1,500 workers in a meat processing plant in [...]
Bloomberg articles: Killing Bugs in the Nose
Bloomberg publishes articles on Steriwave™ nasal photodisinfection International - February 24, 2023 Today, Bloomberg published an article in both its newsletter and in Businessweek about Ondine Biomedical’s Steriwave™ nasal photodisinfection: Newsletter: Killing Bugs in the Nose Businessweek: Germ-Zapping Lasers Help Cut Down on Infections [...]
For Media Information
Simon Vane Percy
Amanda Bernard
